State of the Science Symposia Series: Metabolic Pathways and Therapeutics to Promote Resilience, Rehabilitation

October 25, 2019

Target Audience

The content of the sessions will benefit civilians, veterans, and military service members, their families, care-givers, community-based organizations, government agency personnel, students, residents, and healthcare providers.

Learning Objectives

The overall objective of this course is to provide participants with an overview of current techniques utilized and programs implemented in the area of research and treatment related to metabolic pathways.  The course will attain this objective by showcasing research talks regarding the metabolic pathways and therapeutics to increase resilience, rehabilitation and the ageing process.

Additional Information

Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.00 Attendance
Course opens: 
10/25/2019
Course expires: 
12/31/2020
Event starts: 
10/25/2019 - 8:00am
Event ends: 
10/25/2019 - 3:00pm
Rating: 
0

0800 – 0830

Check-In  │ Continental Breakfast

0830 – 0840

 

 

 

 

0840 - 0900

Opening Remarks - Welcome

COL (ret) Paul Pasquina, MD

Department Chief and Chair, PM&R

Walter Reed National Military Medical Center/Uniformed Services University of the Health Sciences (USUHS)

 

The Importance of Nutrition and Metabolic Research to Military Readiness and Resilience

Patricia Deuster, PhD, MPH, FACSM

Professor and Director Consortium for Health and Military Performance

Uniformed Services University of the Health Sciences (USUHS)

 

0900 – 0925

Overview of Calorie Restriction and Aging as a Field of Research

Yih-Woei Fridell, PhD

Program Officer Division of Aging Biology  

National Institute on Aging, NIH

 

0925 – 0950

 

Time-Restricted Feeding

Rafael de Cabo, PhD  

National Institute on Aging

 

0950 – 1015

 

 

 

1015 – 1040

 

 

 

1040 - 1100

 

1100 – 1125

 

 

 

1125 - 1150

 

Low Calorie Diet for Chemotherapy Augmentation

Sebastian Brandhorst, PhD

University of Southern California                                                     

 

Metformin

Jamie Nicole Justice, PhD                                                                             

Wake Forest School of Medicine                        

 

BREAK

 

Glycolytic Inhibition

Donald Ingram, PhD

Pennington Biomedical Research Center

 

Acarbose

Daniel Larry Smith, PhD

University of Alabama at Birmingham

1150 – 1215

 

 

 

1215 - 1300

Sirtuin Activators and NAD Precursors

Joseph Baur, PhD

University of Pennsylvania

 

LUNCH 

 

1325 – 1350

Rapamycin      

Arlan Richardson, PhD

University of Oklahoma Health Science Center

 

1350 – 1415

 

 

 

1415 – 1430

Ketone Bodies

John Newman, MD, PhD

University of California San Francisco (UCSF)

 

BREAK   

 

1430 – 1455

Senolytic

Yi Zhu, PhD

Mayo Clinic Rochester

 

1455 – 1520

 

 

 

1520 – 1545

 

 

 

1545-1600

PARP Activators

Sajish Mathew PhD

University of South Carolina College of Pharmacy

 

Mitochondrial Derived Peptides

Su-Jeong Kim

University of Southern California

 

Closing Remarks/Adjournment

William K. Smith, MD                                                          COL(ret), Paul Pasquina, MD

Conference Co-Chair, Assistant Professor                           Professor and Chair, Department of PM&R

Department of PM&R, USUHS                                            WRNMMC & USUHS

 

Uniform Services University for the Health Sciences (USUHS), Sanford Auditorium
Bethesda, MD 20817
United States

Faculty Disclosure

All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by patients.

 

The following relevant financial relationships were disclosed:

  • Sebastian Brandhorst is a Scientific Director for the Create Cures Foundation.
  • Donald K. Ingram is a consultant for Isagenix International, Gilbert, AZ and Suntory Wellness, Osaka, Japan and is a stockholder for GeroScience, Inc, Baltimore, MD and Prolongevity Technologies, Baton Rouge, LA.
  • Joseph Baur received grant and research support form Metro Biotech, Elysium Health, Calico (Applied) he also serves as a consultant for Mitobridge, and Calico.
  • Shin-ichiro Imai receives patent and licensing fees from MetroBiotech, USA, and Teijin Limited, Japan, through the Washington University.
  • John Newman is a stockholder for BMB Therapeutics, Ltd.
  • Yi Zhu is a stockholder and receives patents fee on senolytic drugs, held by Mayo Clinic, and licensed to Unity Biotechnology. He has received stocks from Unity Biotechnology.

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The University of Pittsburgh School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.00 Attendance

Accreditation Period

Course opens: 
10/25/2019
Course expires: 
12/31/2020
Please login or register to take this course.